Dr. Zhou received his Ph.D from Shanghai Institutes for Biological Sciences, Chinese Academy of Science in 2005. After graduation he joined Dr. Junming Peng’s lab at Emory University as a postdoctoral fellow, and then he moved to Dr. Richard D. Smith’s lab at Pacific Northwest National Laboratory in 2008 as a postdoctoral research associate. In 2012, he joined in Department of Pathology at Johns Hopkins University as a research associate. Dr. Zhou has been working on proteomics and biomarker discovery for the past 8 years. He has been involved in several national wide large scale biomarker discovery projects for different diseases, including Parkinson’s disease, Alzheimer’s disease, Amyotrophic lateral sclerosis, diabetes, and cancer. He has developed new proteomic techniques to identify and quantify proteins and protein modifications involved in disease development. He is currently focused on the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) project to identify protein and protein modification candidates associated with ovarian cancer and breast cancer. His research interests include the quantitative proteomics and crosstalk between multiple posttranslational modifications.